Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World.
Minato A, Kimuro R, Ohno D, Tanigawa K, Kuretake K, Matsukawa T, Takaba T, Jojima K, Harada M, Higashijima K, Nagata Y, Tomisaki I, Harada K, Fujimoto N, Miyamoto H.
Minato A, et al. Among authors: harada k, harada m.
Anticancer Res. 2023 Sep;43(9):4055-4060. doi: 10.21873/anticanres.16594.
Anticancer Res. 2023.
PMID: 37648337